JPRN-jRCT2031220477招募中1 期
A Phase 1 study of RN-1101 in patients with solid tumor
Yoshimatsu Kentaro0 个研究点目标入组 88 人开始时间: 2022年11月30日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 88
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Cytologically- or histologically-confirmed diagnosis of a locally advanced or metastatic solid tumor
- •2. Refractory to or intolerable with standard treatment, or for which no standard treatment is available
- •3. Age 18 years or older
- •4. Eastern Cooperative Oncology Group (ECOG) Performance Status 0 to 1
- •5. Willing and able to provide informed consent
- •6. Mesureable disease per RECIST version 1.1
排除标准
- •1. Has multiple primary malignancies within 2 years
- •2. Has clinically active brain metastases
- •3. Has a history of Interstitial pneumonia
- •4. Known HIV infection
- •5. Known ative hapatitis B or C infection
- •6. Is pregnant as confirmed or possible, or a lactating mother
研究者
相似试验
未知
1 期
Phase 1 study of ONO-7056Solid tumorJPRN-jRCT2080221709ONO PHARMACEUTICAL CO.,LTD.36
未知
2 期
A M117101 phase II study in patients with primary palmar hyperhidrosisprimary palmar hyperhidrosisJPRN-jRCT2080222374Maruho Co.,Ltd.
未知
1 期
A phase I study of YHI-1001JPRN-jRCT2080221834Yakult Honsha Co., Ltd.18
未知
1 期
Phase 1/2 study of NS-065/NCNP-01 in patients with Duchenne muscular dystrophyDuchenne muscular dystrophyJPRN-jRCT2080223236IPPON SHINYAKU CO., LTD.16
未知
2 期
An early phase 2 study of NST-141 in patients with atopic dermatitisPruritus associated with atopic dermatitisJPRN-jRCT2080221375TAIHO PHARMACEUTICAL CO.,LTD, NIPPON SHINYAKU CO.,LTD120